Galcanezumab-Gnlm

Common brands: Emgality, Imitrex, Topamax, Nurtec Odt, Botox

Top reporter: Eli Lilly And Company

Nonsteroidal Anti-inflammatory Drug [EPC]Acetylcholine Release Inhibitor [EPC]Neuromuscular Blocker [EPC]Benzodiazepine [EPC]Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
30,356
Total Reports
15,321
Serious Reports
81
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.27%)

Patient Demographics

Male
3,485
Female
23,520

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Galcanezumab-Gnlm.

# Reaction Reports % of Total
1 INJECTION SITE PAIN 7,207
19.9%
2 MIGRAINE 2,963
8.2%
3 UNDERDOSE 2,915
8.0%
4 HEADACHE 2,384
6.6%
5 DRUG INEFFECTIVE 1,915
5.3%
6 PRODUCT DOSE OMISSION ISSUE 1,731
4.8%
7 INJECTION SITE HAEMORRHAGE 1,547
4.3%
8 INJECTION SITE ERYTHEMA 1,111
3.1%
9 ACCIDENTAL UNDERDOSE 1,068
2.9%
10 INCORRECT DOSE ADMINISTERED 953
2.6%
11 INJECTION SITE PRURITUS 806
2.2%
12 NAUSEA 804
2.2%
13 INJECTION SITE SWELLING 798
2.2%
14 FATIGUE 736
2.0%
15 INJECTION SITE REACTION 720
2.0%
16 ALOPECIA 709
2.0%
17 INJECTION SITE BRUISING 684
1.9%
18 CONSTIPATION 655
1.8%
19 WEIGHT INCREASED 650
1.8%
20 THERAPEUTIC RESPONSE SHORTENED 645
1.8%
21 DIZZINESS 642
1.8%
22 PAIN 562
1.6%
23 ANXIETY 543
1.5%
24 PRODUCT DOSE OMISSION 537
1.5%
25 ARTHRALGIA 509
1.4%
26 INJECTION SITE URTICARIA 500
1.4%
27 INJECTION SITE MASS 497
1.4%
28 FEELING ABNORMAL 487
1.3%
29 INCORRECT DOSE ADMINISTERED BY DEVICE 484
1.3%
30 PRURITUS 472
1.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.